Gamma Interpharm (Pvt) Ltd. proudly launched Glyclapan MR 60mg, a Gliclazide Modified-Release 60mg tablet, at a prestigious event held at Cinnamon Life – Colombo on March 1st, 2025. This landmark occasion was graced by esteemed medical professionals, key stakeholders, and other distinguished guests, further solidifying Gamma Interpharm’s reputation as a pioneer in Sri Lanka’s pharmaceutical sector.
Glyclapan MR 60 is the first clinically proven Gliclazide Modified-Release 60mg tablet in Sri Lanka. The Bioequivalence (BE) study was successfully conducted at Kotelawala Defence University (KDU), confirming its therapeutic equivalence to the innovator brand. What makes this achievement even more significant is that the study was carried out by Sri Lankans, on Sri Lankans, ensuring that Glyclapan MR 60 is well-suited for the physiological profiles and healthcare needs of the local population.
The guest speaker, Dr. Suma Uday, Consultant Paediatric Endocrinologist at Birmingham Women’s and Children’s Hospital (BWC), delivered discerning speech, bringing attention to the emerging societal issue of childhood obesity and type 2 diabetes, a timely concern. Additionally, Prof. Pandula Athauda-Arachchi, Consultant Interventional Cardiologist and Principal Investigator for the BE studies at KDU, highlighted the significance of bioequivalence (BE) studies and provided valuable insights into how these studies are conducted at KDU aligned to the theme of the event.
With a heritage spanning over six decades, Gamma Interpharm (Pvt) Ltd stands as a pillar of pharmaceutical excellence in Sri Lanka. . From 1995, Interpharm manufactured high-quality generic drugs for both the state and private sectors and later expanded into manufacture of branded pharmaceuticals.
Born from the merger of Gamma Pharmaceuticals (Pvt) Ltd, a pioneer in Sri Lanka’s pharmaceutical industry, which operated as licensees of affiliates of Warner Lambert USA and Pfizer Inc. USA, and Interpharm (Pvt) ltd, Gamma Interpharm (Pvt)Ltd stands strong while having built a legacy of trust and unwavering commitment to quality healthcare. Through our long-standing collaborations, we have gained advanced foreign technology, enhancing our expertise to this day.
The company’s state–of-the-art manufacturing facility in Madapatha, Piliyandala complies with the guidelines for Good Manufacturing Practices (GMP) adopted by the National Medicines Regulatory Authority (NMRA) of Sri Lanka, from the World Health Organization (WHO) GMP main principles for pharmaceutical products. Notably, Gamma Interpharm is at the forefront of conducting Bioequivalence studies in Sri Lanka, ensuring Regulatory compliance and product safety.
Gamma Interpharm (Pvt) Ltd has expanded into Myanmar, the Maldives, Cambodia, Vietnam, and the Philippines, meeting international standards. Its exports earn foreign exchange while supporting the country’s economy by balancing foreign currency flow in the pharmaceutical sector.
The company ensures the highest quality, by sourcing raw materials complying with the latest pharmacopoeial standards, conducting vendor audits regularly, and qualifying machinery through FAT ( Factory Acceptance Tests), before purchase. Market surveillance further guarantees product potency, up to time of use, maintaining excellence in every stage of production and distribution.
Gamma Interpharm(Pvt)ltd, has been playing a crucial role during challenging times, including the COVID-19 pandemic and economic crisis, by ensuring an uninterrupted supply of its products to both government hospitals and the private sector.
Beyond business, Gamma Interpharm (Pvt) ltd actively engages in Corporate Social Responsibility (CSR), contributing to amongst others, the Little Hearts Project at Lady Ridgeway Hospital, island-wide medical camps, health awareness programs, and to school rebuilding projects and public hospital donations.
The launch of Glyclapan MR 60mg marks yet another milestone in Gamma Interpharm’s journey towards pharmaceutical excellence. Gamma Interpharm (Pvt) Ltd.,is a trailblazer in the Sri Lankan pharmaceutical industry, with ambitious plans for regional expansion and continued investment in cutting-edge pharmaceutical research. The company remains steadfast in its commitment to providing high-quality, safe, efficacious, affordable and accessible healthcare solutions for Sri Lanka and beyond.
As a truly Sri Lankan pharmaceutical manufacturer, Gamma Interpharm(Pvt)ltd continues to lead the way, ensuring a healthier future for all.
